Breaking News
April 26, 2018 - UNC-Chapel Hill receives new award to help improve health of North Carolinians
April 26, 2018 - Study finds no evidence of chronic wasting disease transmissibility in macaques
April 26, 2018 - Study highlights impact of early detection on skin cancer survival
April 26, 2018 - Scientists discover culprit in reducing effectiveness of insulin
April 26, 2018 - Exploiting rabies virus machinery to usher Parkinson’s disease drug directly to the brain
April 26, 2018 - ‘Rapid autopsy’ programs seek clues to cancer within hours of death
April 26, 2018 - Personalised prescriptions according to your genetics
April 26, 2018 - ECDC analysis highlights measles vaccination gaps in teenagers and young adults
April 26, 2018 - Study assesses link between cognitive function levels and crash risk among older drivers
April 26, 2018 - Researchers uncover how obesity leads to cancer initiation
April 26, 2018 - Consuming large quantities of sugar during pregnancy can affect child’s cognition, shows study
April 26, 2018 - Researchers create new tool to measure patient uncertainty for predicting hospital readmissions
April 26, 2018 - FDA Alert: Lamictal (lamotrigine): Drug Safety Communication
April 26, 2018 - Massive single-cell survey of kidney cell types reveals new paths to disease
April 26, 2018 - Cognitive behavioral therapy can help children with autism manage emotional challenges
April 26, 2018 - CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments
April 26, 2018 - Researchers discover significant distortions in leading genetics study method
April 26, 2018 - New combination therapy could improve survival in children with high-risk neuroblastoma
April 26, 2018 - Scientists clarify casual role of oxidative stress in metabolically abnormal and healthy obesities
April 26, 2018 - Home-based exercise program found ineffective for patients with peripheral artery disease
April 26, 2018 - New UCLA study could elucidate certain causes of infertility and miscarriage
April 26, 2018 - Choroidal Thickness Changes in Patients With Untreated DM
April 26, 2018 - Medical chemists discover peptic ulcer treatment metallodrug effective in ‘taming’ superbugs
April 26, 2018 - UB researchers build 3D-printed, drug-filled dentures to fight against infections
April 26, 2018 - Researchers find role of iron storage gene in slowing down prostate cancer growth
April 26, 2018 - Study suggests link between regular mid-day naps and neurocognitive function in teens
April 26, 2018 - Researchers gain ground-breaking insights into how inflammatory diseases work
April 26, 2018 - Injured U.S. Vet Receives World’s First Penis/Scrotum Transplant
April 26, 2018 - Researchers find existing drug effective at preventing onset of type 1 diabetes
April 26, 2018 - MGH researchers identify risk factors for drug overdose in youth with substance use disorders
April 26, 2018 - Researchers develop new vaccine to help people overcome bath salts abuse
April 26, 2018 - Genetic signature predicts diabetes diagnosis
April 26, 2018 - Study shows link between restless legs syndrome symptoms and brain structure
April 26, 2018 - MU researchers use new techniques to fight against diabetic retinopathy
April 26, 2018 - AAE’s new practice statements aim at improving patient care
April 26, 2018 - Expression of long non-coding RNAs can result in high levels of specific proteins involved in cancer
April 26, 2018 - FDA re-examining safety of new drug approved for Parkinson’s disease psychosis
April 26, 2018 - Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy
April 26, 2018 - Bacteria boost antifungal drug resistance in severe childhood tooth decay
April 26, 2018 - New study affirms bedtime habits of Americans
April 26, 2018 - Hospital patients are more interested in tracking their health data, research shows
April 26, 2018 - Study shows gene variations associated with malaria risk
April 26, 2018 - Inhealthcare teams up with MSKassist to combat problems related to obesity and aging
April 26, 2018 - Caffeine during pregnancy – babies 66 percent more likely to become overweight
April 26, 2018 - FDA Approves Jynarque (tolvaptan) to Slow Kidney Function Decline in Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease
April 26, 2018 - Pricey dental implants often best but insurance rarely pays
April 26, 2018 - Advion’s Peak Express software now available with the expression compact mass spectrometer
April 25, 2018 - Researchers find link between pneumonia in older people and PPI prescriptions
April 25, 2018 - Alcohol damages microbiome in the mouth
April 25, 2018 - Regular soaking in hot tub improves health outlook in obese women with PCOS
April 25, 2018 - FDA Alert: Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Devices: Letter to Health Care Providers
April 25, 2018 - Sunshine could hold clues on the timing for a severe form of heart attack, study says
April 25, 2018 - Sartorius Stedim Biotech launches mini bioreactor vessel for ambr 250 high throughput system
April 25, 2018 - Biofeedback-assisted relaxation may help children during medical procedures
April 25, 2018 - Key signaling protein in Huntington’s disease found to have deleterious effects on heart function, shows study
April 25, 2018 - Celecoxib Lowers Opioid Use Post Head & Neck Cancer Surgery
April 25, 2018 - New ‘brain health index’ can predict how well patients will do after stroke
April 25, 2018 - Positive interventions in sepsis management raise key questions about E. coli reduction targets
April 25, 2018 - Scientists identify new DNA structure within living human cells
April 25, 2018 - E. coli’s toxin-antitoxin system inhibits bacterial growth
April 25, 2018 - Researchers uncover reason why exercise may be beneficial for the heart
April 25, 2018 - Researcher presents case study of asymptomatic patient with severe mitral regurgitation
April 25, 2018 - Use ‘Proper Form’ When Practicing Yoga
April 25, 2018 - Study reports possible novel method for stopping untreatable pediatric brain cancers
April 25, 2018 - Visually guided walking paves way for better treatment for mobility impairments
April 25, 2018 - Researchers identify novel pathway in development of AML with poor prognosis
April 25, 2018 - Cardiovascular disease may only be a matter of time for people with healthy obesity
April 25, 2018 - Girls with type 2 diabetes have high frequency of menstrual irregularities
April 25, 2018 - Study explains why intense exercise curbs appetite
April 25, 2018 - Experimental drug for rheumatoid arthritis prevents side effect of stem cell transplants
April 25, 2018 - Why are Antibiotics Overprescribed for Meningitis Treatment?
April 25, 2018 - Consuming protein supplements with meals, rather than between meals, may promote weight control
April 25, 2018 - Seeing prostate cancer in a new light
April 25, 2018 - Jacobs Medical Center recognized with Baby Friendly Designation for efforts in mother-baby bonding
April 25, 2018 - Gene related to high fatality could be used as biomarker in patients with P. aeruginosa infection
April 25, 2018 - Study shows patients in major prostate cancer study are more likely to die than real-world patients
April 25, 2018 - HBP researchers develop new tool to examine role of genes in disease-relevant brain regions
April 25, 2018 - Trio’s pioneering silicone ostomy product wins prestigious Queen’s Award for Enterprise
April 25, 2018 - Study highlights potential of stem cells derived from adults in regenerative medicine
April 25, 2018 - A new, emerging procedure burns cancer cells
Gyn Cancer Research Gets Short Shrift in Funding

Gyn Cancer Research Gets Short Shrift in Funding

image_pdfDownload PDFimage_print

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.

NEW ORLEANS — Federal funding for medical research severely short changes gynecologic oncology when cancer lethality is taken into account, according to data presented here.

Among 13 common cancers included in the analysis, gynecologic cancers ranked near the bottom in funding support, as determined by federal spending per years of life lost for each type of cancer. Three gynecologic cancers used for the analysis — ovarian, cervical, and uterine — landed near the bottom of the list individually and collectively.

A comparison of ovarian and prostate cancer, for example, showed a mean expenditure of $85,000 per years of life lost (YLL) per 100 new cases of ovarian cancer. The mean soared beyond $1 million for prostate cancer. Even greater disparities resulted from analyses involving cervical and uterine cancer, Ryan Spencer, MD, of the University of Wisconsin in Madison, reported at the Society of Gynecologic Oncology (SGO) meeting.

“We observed that gynecologic cancers are disproportionately underfunded compared to most other cancer sites when using the funding-to-lethality score to standardize the impact of mortality, incidence, and person years of life lost to cancer death across various cancer sites,” said Spencer. “These disparities are seen when the data are aggregated and when the data are re-analyzed by individual year and when year-over-year trends are explored.

“Given current funding projections and the decline in clinical trial availability, these trends are likely to continue to worsen, rather than improve.”

SGO invited discussant Paola Gehrig, MD, of the University of North Carolina at Chapel Hill, noted that federal funding for clinical trials in all types of cancer has declined substantially in recent years. For example, the NCI funded 27% of new research proposals in 2001, but that declined to 12% by 2015. From 2008 to 2017, the number of fully funded NIH studies presented at the American Society of Clinical Oncology meeting decreased by 75%.

However, outcomes in at least some gynecologic cancers have not improved to the same degree as some common cancers during the decline in federal funding. Using her specialty of uterine cancer as an example, Gehrig noted that disease-specific mortality for uterine cancer increased 2% annually from 2010 to 2014.

Borrowing a statement from Spencer’s presentation, Gehrig concluded, “Without a correction, gynecologic cancers will continue to be underfunded and risk lagging behind other cancer sites in critical discoveries for cure and life prolongation, in this important era of immunotherapy, molecular targeting, and personalized medicine.”

The study had its origin in what Spencer described as a crisis in enrollment in gynecologic cancer clinical trials. From 2011 to 2016, enrollment in gyn cancer trials decreased by 90%, and the number of available trials declined by 68%. The objective was to determine the equability of NCI funding distributions across different types of cancer.

Data for the analyses came from the NCI Surveillance, Epidemiology, and End Results registry program and the Cancer Trends Progress Report and funding statistics for the years 2007-2014.

Investigators calculated a “funding-to-lethality” score for uterine, ovarian, and cervical cancer, as well as for 10 other types of cancer. The comparators included a mix of common diseases (breast, lung, prostate, colon), cancers with incidences similar to the gyn cancers, and cancers that affect only men (prostate, testicular).

To achieve a balance among cancer incidence, mortality, and burden of YLL, investigators determined YLL for each of the 13 cancers included in the analysis and then used federal funding for each of the cancers to calculate funding-to-lethality values.

In the overall analysis, prostate and breast cancer came out far ahead of all the other types of cancer. From 2007-2014, prostate cancer had a funding-to-lethality score of 1.811, which translated into $1,811,000 per YLL per 100 new cases. Breast cancer followed close behind with a score of 1.803 and $1,803,000 per YLL per 100 cases. Ovarian cancer ranked 9th (0.97, $97,000), cervical cancer ranked 10th (0.87, $87,000), and uterine cancer ranked 12th (0.057, $57,000). Testicular cancer came in last (0.044, $44,000).

Using the data for 2014, Spencer’s group compared ovarian and prostate cancers. Ovarian cancer had a mortality of 7.0191 deaths/100,000, versus 19.1189/100,000 for prostate cancer, and an incidence of 11,3496/100,000 versus 99.6716/100,000. Dividing mortality by incidence resulted in 0.618 deaths per new cancer for ovarian cancer and 0.192 for prostate cancer.

Multiplying the deaths per new cancer by 17.5 years of life lost to death by ovarian cancer and 9.9 years of life lost with each prostate cancer death yielded 1,282 YLL per 100 new cases of ovarian cancer and 189.9 YLL/100 for prostate cancer.

Finally, investigators divided the $91.5 million in funding by the YLL to arrive at $85,000/YLL/100 new cases and a funding-to-lethality score of 0.085 for ovarian cancer. The same calculations with $217.8 million in funding for prostate cancer resulted in $1,147,000 per YLL/100 and a funding-to-lethality score of 1.15.

Across the entire study period, the funding-to-lethality scores and funding per YLL per 100 new cases for the other cancers were:

  • Melanoma: -0.519 and $519,000
  • Colorectal: -0.422 and $442,000
  • Lung: -0.3 and $363,000
  • Leukemia: -0.353 and $353,000
  • Non-Hodgkin’s lymphoma: -0.284 and $284,000
  • Kidney: -0.112 and $112,000
  • Pancreas: -0.074 and $74,000

Spencer acknowledged several limitations of the study. The analysis did not account for funding from sources other than NCI. Funding gaps are likely multifactorial. A “correct” or “appropriate” funding-to-lethality score has not been determined.

Spencer and colleagues disclosed no relevant relationships with industry.

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles